Products billed under this code include ALBUMINEX 5%, Albuked 5, Albumin (Human), Alburx, Albutein, Buminate, Plasbumin-5.
Payment limit per 250 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| ALBUMINEX 5% | Bio Products Laboratory USA, Inc. | 64208-2510-01 | 1 | $53.079 |
| ALBUMINEX 5% | Bio Products Laboratory USA, Inc. | 64208-2510-05 | 2 | $106.158 |
| Albuked 5 | Kedrion Biopharma | 76125-0790-25 | 1 | $53.079 |
| Albumin (Human) | Octapharma USA | 68982-0623-02 | 1 | $53.079 |
| Albumin (Human) | Octapharma USA | 68982-0623-03 | 2 | $106.158 |
| Alburx | CSL Behring | 44206-0310-25 | 1 | $53.079 |
| Alburx | CSL Behring | 44206-0310-50 | 2 | $106.158 |
| Albutein | Grifols | 68516-5214-00 | 4 | $212.316 |
| Albutein | Grifols | 68516-5214-01 | 1 | $53.079 |
| Albutein | Grifols | 68516-5214-02 | 2 | $106.158 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Albutein | Grifols | 68516-5214-09 | 4 | $212.316 |
| Albutein | Grifols | 68516-5218-04 | 4 | $212.316 |
| Albutein | Grifols | 68516-5219-02 | 4 | $212.316 |
| Buminate | Baxter | 00944-0491-01 | 1 | $53.079 |
| Buminate | Baxter | 00944-0491-02 | 2 | $106.158 |
| Plasbumin-5 | Talecris | 13533-0685-20 | 0.2 | $10.6158 |
| Plasbumin-5 | Talecris | 13533-0685-25 | 1 | $53.079 |
| Plasbumin-5 | Talecris | 13533-0690-20 | 0.2 | $10.6158 |
| Plasbumin-5 | Talecris | 13533-0690-25 | 1 | $53.079 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $53.079 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted September 17, 2026 |
| 3Q26 | $53.079 | +$0.002 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted September 15, 2026 |
| 2Q26 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted September 15, 2026 |
| 1Q26 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted September 15, 2026 |
| 4Q25 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted September 8, 2026 |
| 3Q25 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted March 10, 2026 |
| 2Q25 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted March 10, 2026 |
| 1Q25 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted December 19, 2025 |
| 4Q24 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted June 11, 2025 |
| 3Q24 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted June 11, 2025 |
| 2Q24 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted March 11, 2025 |
| 1Q24 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted December 19, 2024 |
| 4Q23 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted October 10, 2024 |
| 3Q23 | $53.077 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted June 5, 2024 |
| 2Q23 | $53.077 | +$0.304 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted February 23, 2024 |
| 1Q23 | $52.773 | +$0.323 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted December 6, 2023 |
| 4Q22 | $52.45 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted June 22, 2023 |
| 3Q22 | $52.45 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted June 9, 2023 |
| 2Q22 | $52.45 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted December 14, 2022 |
| 1Q22 | $52.45 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted June 8, 2022 |
| 4Q21 | $52.45 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted June 2, 2022 |
| 3Q21 | $52.45 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted June 2, 2022 |
| 2Q21 | $52.45 | $0.00 | 250 ML | Albumin (human), 5%, 250 ml | v1, posted March 1, 2022 |
| 1Q21 | $52.45 | – | 250 ML | Albumin (human), 5%, 250 ml | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
